BRPI0402756A - method for treating cognitive disorders - Google Patents
method for treating cognitive disordersInfo
- Publication number
- BRPI0402756A BRPI0402756A BRPI0402756A BRPI0402756A BR PI0402756 A BRPI0402756 A BR PI0402756A BR PI0402756 A BRPI0402756 A BR PI0402756A BR PI0402756 A BRPI0402756 A BR PI0402756A
- Authority
- BR
- Brazil
- Prior art keywords
- cognitive disorders
- treating cognitive
- carbamoylseroline
- alzheimer
- phenyl
- Prior art date
Links
- 208000010877 cognitive disease Diseases 0.000 title abstract 3
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
"MéTODO PARA O TRATAMENTO DE DISTúRBIOS COGNITIVOS". A presente invenção refere-se a composições e métodos para o tratamento de doenças que resultam de distúrbios cognitivos, tal como doença de Alzheimer com o composto (-)N-(-)-N fenil carbamoileserolina como o ingrediente ativo."METHOD FOR TREATMENT OF COGNITIVE DISORDERS". The present invention relates to compositions and methods for treating diseases resulting from cognitive disorders, such as Alzheimer's disease with the compound (-) N - (-) - N phenyl carbamoylseroline as the active ingredient.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BRPI0402756 BRPI0402756A (en) | 2004-07-09 | 2004-07-09 | method for treating cognitive disorders |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BRPI0402756 BRPI0402756A (en) | 2004-07-09 | 2004-07-09 | method for treating cognitive disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0402756A true BRPI0402756A (en) | 2006-02-21 |
Family
ID=36046266
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0402756 BRPI0402756A (en) | 2004-07-09 | 2004-07-09 | method for treating cognitive disorders |
Country Status (1)
| Country | Link |
|---|---|
| BR (1) | BRPI0402756A (en) |
-
2004
- 2004-07-09 BR BRPI0402756 patent/BRPI0402756A/en not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP055719A (en) | TIAZOL COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS | |
| UY28817A1 (en) | IMIDAZOL COMPOUNDS FOR THE TREATMENT OF NEURODEGERATIVE DISORDERS | |
| BR0315158A (en) | Pyrazole Compounds for the Treatment of Neurodegenative Disorders | |
| UY27872A1 (en) | CASPASA INHIBITORS AND USES OF THE SAME. | |
| EA201071243A1 (en) | COMBINED COMPOSITIONS FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND RELATED DISEASES WITH ZONISSMID AND ACAPROSAT | |
| UY30377A1 (en) | FUSIONATED TRICYCLE INHIBITORS OF SULFONAMIDE OF GAMA-SECRETASA | |
| ATE389395T1 (en) | SUBSTITUTED 2-AMINOTETRALINE FOR THE PREVENTIVE TREATMENT OF PARKINSON'S DISEASE | |
| ATE489948T1 (en) | TREATMENT OF AUTOIMMUNE DISEASES | |
| TW200716152A (en) | Substituted 1,2-ethylendiamines, medicaments comprising said compound, their use and their method of manufacture | |
| UY28484A1 (en) | COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS | |
| BR0306855A (en) | Method for the treatment of cognitive disorders | |
| BR0316723A (en) | Anilinopyrazole derivatives useful for the treatment of diabetes | |
| MX2010000956A (en) | Compounds which inhibit beta-secretase activity and methods of use thereof. | |
| ECSP088280A (en) | IMIDAZOL COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS | |
| DOP2005000049A (en) | SULFONAMID COMPOUNDS FOR THE TREATMENT OF NEURODEGERERATIVE DISORDERS | |
| UY28458A1 (en) | OXAZOL COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS | |
| DE502004006525D1 (en) | USE OF FIGURE CACTUS (OPUNTIA) FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF DEPRESSIONS | |
| DE602005015697D1 (en) | TE FOR THE TREATMENT OF ALZHEIMER DISEASE | |
| ATE402150T1 (en) | PYRAZOLAMINE COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | |
| BRPI0402756A (en) | method for treating cognitive disorders | |
| ATE505193T1 (en) | DRUG COMBINATIONS FOR THE TREATMENT OF RESPIRATORY DISEASES | |
| BRPI0509881A (en) | therapeutic combination for treatment of alzheimer's disease | |
| DOP2004000982A (en) | COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS | |
| DOP2004000970A (en) | OXAZOL COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS | |
| DOP2003000728A (en) | TIAZOL COMPOUNDS FOR THE TREATMENT OF NEURODEGENETIVE DISORDERS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired |